0
Laboratory and Animal Investigations |

Pleurodesis Is Inhibited by Anti-Vascular Endothelial Growth Factor Antibody*

Yubiao B. Guo, MD; Ioannis Kalomenidis, MD; Michael Hawthorne, MD; Kelly S. Parman, MS; Kirk B. Lane, PhD; Richard W. Light, MD, FCCP
Author and Funding Information

*From the Department of Respiratory and Critical Care Medicine (Dr. Guo), the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ROC; Department of Critical Care and Pulmonary Services (Dr. Kalomenidis), Athens Medical School, Evangelismos Hospital, Athens, Greece; Mouse Pathology and Immunostaining Core Facility (Ms. Parman), Vanderbilt University Medical Center, Nashville, TN; and Department of Pulmonary Medicine (Drs. Hawthorne, Lane, and Light), St. Thomas Hospital and Vanderbilt University, Nashville, TN.

Correspondence to: Richard W. Light, MD, FCCP, Department of Pulmonary Medicine, St. Thomas Hospital, 4220 Harding Rd, Nashville, TN 37205; e-mail: rlight98@yahoo.com



Chest. 2005;128(3):1790-1797. doi:10.1378/chest.128.3.1790
Text Size: A A A
Published online

Study objectives: The intrapleural injection of transforming growth factor (TGF)-β2 produces pleurodesis in rabbits associated with large pleural effusions. This study investigated whether anti-vascular endothelial growth factor (VEGF) antibody has any effect on the fluid production or the pleurodesis induced by TGF-β2.

Interventions and measurements: Three groups of seven New Zealand white rabbits were administered TGF-β2 5.0 μg intrapleurally. Two groups received anti-VEGF antibody (10 mg/kg and 25 mg/kg) IV 24 h before TGF-β2 injection, and the third group received no antibody. The rabbits were killed at 2 weeks, and the macroscopic pleurodesis score was determined. The degree of pleural angiogenesis was assessed by immunohistochemical staining for factor VIII.

Results: The administration of anti-VEGF antibodies had no significant effect on the pleural fluid volume or the characteristics of the fluid. The mean pleurodesis score of the seven rabbits in the control group (7.71 ± 0.76) was significantly (p < 0.05) higher than that for seven rabbits in the low-dose treatment group (4.43 ± 2.37) and the seven rabbits in the high-dose treatment group (4.57 ± 2.36) [± ]. The percentage of pleural tissue demonstrating angiogenesis in the control group (4.87 ± 0.43%) was significantly (p < 0.05) higher than that for the low-dose (2.94 ± 0.68%) or high-dose (2.67 ± 0.64%) antibody groups. When all rabbits were considered, there was a highly significant correlation between the pleural vascular density scores and the pleurodesis scores (r = 0.84, p < 0.01).

Conclusion: VEGF and angiogenesis appear to play a pivotal role in the production of a pleurodesis.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543